This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTCF8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,173.43, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of November 27, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 2/25/25, 10:07 AM